Tag: vaccines

New paper shows COVID boosters increased mortality in nursing home residents. The effect was highly statistically significant after 4 weeks.

A new paper by Girma and Paton showed by using machine learning a small but dubious (and short lived) benefit for nursing home residents in 2 of 3 metrics. In other words, they couldn’t find a definitive benefit for the primary series and they found NO benefit for additional shots.

In fact, for the boosters, they found a highly statistically significant INCREASE in COVID mortality after the boosters were administered.

We should only be giving these shots if there is a clear and significant benefit, not “we aren’t sure” or “there is no benefit.” But when there is a highly statistically significant harm, alarm bells should go off!

The paper says, “Indeed, in the later period, we find some evidence that higher vaccination rates are associated with higher Covid mortality.” A safe and effective vaccine shouldn’t be even close to causing a conclusion like that.

Additionally, vaccinating the nursing home staff also appeared to have a negative impact on residents. There, the impact on both COVID deaths and all-cause deaths was 100% consistent in all 7 time periods and for each vaccine dose: it always made things worse, and for the primary series where every single one of the 14 measures were highly statistically significant (99% confident).

This is yet another paper showing continuation of COVID vaccination is nonsensical. But the data doesn’t seem to matter and nobody wants to talk about it.

As usual, expect the mainstream media to ignore this paper as they do for any paper that shows that the health interventions were detrimental.

Keep reading

In Email Obtained by ICAN, a Fauci Senior Advisor Admits CDC’s Data “Shockingly Messed Up” and Leaders Have “Serious Issues”

During a recent Congressional hearing, we learned that David Morens prided himself on his ability to avoid transparency and purposefully evade FOIA. The hearing revealed emails in which Morens boasted that he “learned from our [FOIA] lady here how to make most emails disappear” and “we are all smart enough to know to never have smoking guns, and if we did we wouldn’t put them in emails and if we found them we’d delete them.”

But in a recent FOIA production obtained by ICAN’s attorneys, we discovered that Morens failed to delete at least one smoking gun. In an April 2020 email to Greg Folkers, Fauci’s Chief of Staff, Morens made an astonishing admission about CDC’s long-term incompetence in handling data and NIH’s willingness to cover it up:

Greg, please keep this confidential but you should know that for over a decade the flu folks at CDC have shockingly messed up their tabulations of flu mortality. We discovered 5-10 years ago that various web page and published data were totally inconsistent and could only be explained by major uncaught errors[.]

… apparently various folks in [t]he flu division made and put up and published mutually-inconsistent figures based on differing subjective assumptions[.]

Several years ago, maybe 4-5, we reached out to the top flu people at CDC informing them that their own data were problematic, that as a sister agency we did NOT want to draw attention to it but work with them privately to fix and reconcile the problems. At first they were grateful, and set up a mechani[sm] to work with us, but then when they discovered the depths of their own mistakes … they did the usual CDC thing and circled the wagons, refused to return calls and emails, etc. [W]e didn’t pursue things but were left unsettled.

To repeat, this was at the level of cdc’s flu leadership. I think we have to accept that they have serious issues and have not fixed them.

Let’s not forget that throughout the COVID-19 pandemic, we were told to “trust the experts,” many of whom worked for CDC. Recommendations and edicts handed down from on high at CDC were treated as gospel. The few brave souls who had the courage to publicly question CDC’s judgment were met with derision, pejoratives, censorship, and attacks on their careers and reputations. This makes it all the more infuriating to learn that, according to Morens, the “usual CDC thing” to do when its mistakes are discovered is to ignore the problem and refuse to discuss it—even when the mistake is discovered by another government agency!

Keep reading

‘Should Not Be Used in Any Infants’: Higher Death Risk in Beyfortus RSV Shot Clinical Trials

Infants treated for RSV with the monoclonal antibody nirsevimab have significantly higher mortality rates than those treated with a different monoclonal antibody or with a placebo, according to an analysis by the Japanese journal Med Check of three major randomized control trials.

The report reanalyzed clinical trial data showing that nirsevimab — marketed by Sanofi and AstraZeneca as Beyfortus — reduced RSV-associated lower respiratory tract infection and hospitalizations in both high-risk and healthy infants.

However, babies treated with the drug had a higher mortality rate likely linked to adverse effects — including thrombosis (blood clotting) — from the drug itself, the study found.

“Due to the increased mortality, nirsevimab should not be used in any infants,” the study concluded. “Do not use nirsevimab for universal immunization.”

Shortly after its approval by the European Medicines Association in October 2022, and fast-track approval by the U.S. Food and Drug Administration in July 2023, the U.S., France, Spain and Luxembourg launched universal Beyfortus infant immunization campaigns for the 2023-24 RSV season.

Med Check published its appraisal of the clinical trials shortly after France’s National Agency for the Safety of Medicines and Health Products (ANSM) published its first pharmacovigilance data on the drug, compiled during the 2023-24 season.

The ANSM report tracked adverse events related to Beyfortus in France between Sept. 11, 2023, and April 30, 2024. Of 244,495 doses delivered, 198 adverse events were reported to the pharmacovigilance system, of which 153 were considered serious.

The report identified safety signals for stroke, respiratory conditions and hypotonic-hyporesponsive episodes — when an infant suddenly loses muscle strength and becomes “floppy.” Hypotonic-hyporesponsive episodes also are associated with the diphtheria-tetanus-pertussis, or Tdap, vaccine and other vaccines.

There were also three reports of sudden infant death syndrome (SIDS), although researchers said at least one of them was likely not linked to the drug.

The ANSM said each of the signals would be closely monitored in the future, but that a causal link between Beyfortus and those adverse events had not yet been established. The agency concluded the results confirm that the benefits of using the drug to treat bronchiolitis, an RSV infection, outweigh the risks.

The ANSM continues to recommend all newborn babies receive the Beyfortus shot this RSV season.

Keep reading

FDA Brushed Off Concerns About DNA Fragments in Gardasil’s HPV Vaccine

Over the last two years, cancer genomic experts have raised concerns about the presence of residual DNA fragments in the mRNA COVID-19 vaccines, saying that it has the potential to increase the risk of developing cancer.

This mirrors the concerns raised several years ago about the safety of the Gardasil human papillomavirus (HPV) vaccine, manufactured by Merck & Co.

In 2011, Sin Hang Lee, a pathologist and 30-year veteran in DNA analysis, made the startling discovery of synthetic DNA fragments in several vials.

“I was shocked to find DNA fragments in the HPV vaccine because DNA is not supposed to be there,” Lee recalls.

“They use DNA to make the vaccine, but then it is supposed to be chopped up and removed in the manufacturing process,” he said.

Lee, an internationally recognized expert in molecular gene detection, carefully documented his findings in a report that was sent to the U.S. Food and Drug Administration (FDA) for review.

The FDA investigated.

On Sept. 23, 2011, the FDA’s Center for Biological Evaluation and Research (CEBR) responded by saying it had evaluated the concerns in Lee’s report, and determined that the Gardasil vaccine was “safe and effective.”

The FDA did acknowledge that Lee found residual DNA in the vaccine, but said it was “expected” and “inevitable” in products that are manufactured using recombinant technology.

The agency also said it remained confident that the residual DNA was “not a risk to vaccine recipients.”

“The presence of residual DNA is not a safety factor as defined by US regulations, and is not required to be included in Gardasil’s labeling,” wrote the FDA.

The following month (Oct. 21, 2011) the FDA quietly updated its website to reflect the presence of DNA fragments in the vaccine, assuring the public there was “no safety risk.”

Keep reading

‘Reckless Disregard for the Truth’: Shareholders Sue Moderna for Misleading Investors on RSV Shot Efficacy

A group of shareholders is suing Moderna alleging the company knowingly inflated claims about the efficacy of its RSV vaccine for older adults. When the drugmaker later lowered expectations for the vaccine’s efficacy the stock price dropped precipitously.

A class-action lawsuit accuses Moderna of making “materially false and misleading statements” about the efficacy of its respiratory syncytial virus (RSV) shot, leading to significant damages for investors.

The lawsuit, filed Aug. 9 in the U.S. District Court for the District of Massachusetts, covers investors who owned or purchased Moderna stock between Jan. 18, 2023 — the day that Moderna announced that mRNA-1345, its candidate RSV vaccine, met primary efficacy endpoints in Phase 3 clinical trials — and June 25, 2024.

According to the lawsuit, Moderna misled investors by failing to disclose that “mRNA-1345 was less effective than Defendants had led investors to believe” and that “mRNA-1345’s clinical and/or commercial prospects were overstated.”

“As a result, the Company’s public statements were materially false and misleading at all relevant times,” the lawsuit states.

The lawsuit names Moderna and its key executives, including its CEO Stéphane Bancel, Chief Financial Officer James M. Mock and President Stephen Hoge, as defendants.

“Defendants acted with reckless disregard for the truth in that they failed or refused to ascertain and disclose such facts as would reveal the materially false and misleading nature of the statements made, although such facts were readily available to Defendants,” the lawsuit states.

Brian Hooker, Ph.D., chief scientific officer for Children’s Health Defense (CHD), told The Defender he is not surprised by allegations of fraud concerning Moderna.

“It is unfortunate that Moderna lied about the efficacy of the vaccine and misled investors,” Hooker said. But Hooker said the “bigger tragedy here is the lack of safety testing for modified mRNA products such as their RSV shot.”

Keep reading

Survey Reveals Over One in Six Germans Report Side Effects from COVID-19 Vaccination

As the world reflects on the aftermath of the COVID-19 pandemic, alarming new data from Germany reveals that the experimental COVID vaccines, may have left far more harm in their wake than originally acknowledged.

A recent survey conducted by the Forsa Institute shows that over one in six Germans report experiencing side effects from their vaccination—an undeniable red flag that mainstream media continues to downplay.

The representative survey conducted on behalf of the German newspaper “Neue Osnabrücker Zeitung” (NOZ) and the online magazine “Multipolar,” polled 1,002 individuals on October 7 and 8.

According to the survey results, more than one in six Germans has experienced side effects due to the COVID-19 vaccine.

A significant 17 percent of respondents openly stated they did not “tolerate the COVID vaccination well overall.” This figure challenges the widespread narrative of “safe and effective” vaccinations promoted by health agencies worldwide.

Meanwhile, 10 percent of respondents reported not receiving the vaccine.

Though 73 percent reported no adverse reactions, the data still leaves a considerable group of Germans facing unsettling vaccine side effects.

Keep reading

Slovak government’s investigation into the covid pandemic finds it was a “fabricated operation” and calls for ban on mRNA injections

The Slovak government commissioner for investigating the management of the coronavirus pandemic, Peter Kotlár, considers mRNA injections to be dangerous and has called for a ban. He also calls the covid pandemic an “act of bioterrorism” and a “fabricated operation.”

On 2 October, after it had been submitted to the Government, Kotlár gave a press conference about his report.  The key recommendations from his report include halting the use of mRNA “vaccines,” that SARS-CoV-2 was artificially created in a laboratory and deliberately spread worldwide, and ending Slovakia’s cooperation with the World Health Organisation.  The report will be made public “but let’s wait first for a session of the government,” he said.

“The most serious consequence of the whole fabricated operation called the covid-19 pandemic is the endangerment of human health and the confirmation of the naivety of the world population to be subconsciously obedient,” Kotlár said.

“Let us at least make the right gesture together by stopping the administration of mRNA preparations until their effectiveness and safety have been proven,” Kotlar demanded when presenting his report. The most serious finding is that mRNA preparations alter human DNA, he claims. The vaccines have been inadequately tested and are therefore dangerous.

Keep reading

Top Japanese medics are “Gunning for Gates”

“Japan Warns Bill Gates His “Days Are Numbered” After Abortion Drugs Found in Vaccines Japan has sent a clear message to Bill Gates – his time is running out.

With the government’s Covid Task Force swiftly uncovering his crimes, the walls are closing in on the globalist kingpin. Japanese scientists are now taking a stand, urging international prosecutors to bring a case of crimes against humanity against Gates.

Among them, world-renowned experts like Dr. Fukushima are raising the alarm, revealing shocking discoveries that some vaccines contain abortion drugs designed for depopulation. They warn that there is overwhelming evidence suggesting Gates isn’t finished yet – he has plans to inflict even more harm in the near future. It’s time for the world to unite and bring him to justice!”

Keep reading

There will never be a vaccine for respiratory viruses to prevent infection or spread; RSV is no exception

Countless concerned parents have asked the WCH about the new RSV vaccines. In this post, we look at what they are, as well as the virus itself, with the aim of helping readers make their own informed decisions. The post is in two parts. First, a summary of the most salient points. Then, a more academic paper into the context and science for health professionals and others looking to gain a deeper perspective.

Part 1: The “TLDR” Summary

[Note: “TDLR” is an abbreviation for “too long; didn’t read.” It is used to indicate that one didn’t read the whole text or to indicate that what follows is a summary of the overly long text.]

  • RSV symptoms are mild and mimic the common cold. Most babies have been infected with RSV by their second birthday. In the EU, more than 90% of hospitalised adult RSV patients are over 65 years old.
  • It is easily treated with nebuliser therapy. Urgent care and hospitalisation can occur for serious cases and if treated early, infant mortality should not be a concern. Among the 22.4 million children under 5 years old in the US, the annual risk of RSV hospitalisation is well under 1%.
  • RSV “vaccines” only reduce the risk of hospitalisation from RSV by 1%.
  • So-called RSV “vaccines” fall into three categories: monoclonal antibodies, a protein-based “vaccine,” and mRNA technology.
  • The monoclonal antibody treatment is called nirsevimab and is given in a single dose. There are serious safety concerns around nirsevimab. The clinical trials had limitations and there is little to no long-term safety data. Ambiguity around its classification also complicates safety monitoring and accountability.
  • Some reports link nirsevimab to infant deaths. Many treated infants still end up in hospital, and resistant strains of the virus are emerging. Antibody-dependent enhancement (“ADE”) is also a concern.
  • Recent vaccines developed by GSK and Pfizer for pregnant women have shown a 2% increase in premature births and higher rates of neonatal deaths in trials.
  • Moderna’s mResvia mRNA vaccine is recommended by the European Medicines Agency for the over-sixties, yet with no data showing it’s either safe or effective. The same safety concerns exist for mResvia as for any other mRNA “vaccine,” namely myocarditis, auto-immunity, genomic integration and cancer.
  • There are alternatives. Studies show a clear inverse relationship of severity of RSV symptoms and vitamin D levels. Better vitamin D levels may lower the incidence of RSV-associated bronchiolitis in infants, and vitamin D helps enhance immune response, reduce inflammation and helps stop RSV getting into cells. Quercetin and zinc are also worth consideration as part of a treatment protocol.

If you’d like to discuss these points with your doctor or other health professional, consider sharing the following detailed paper with them. It includes aspects many vaccinating doctors have not been informed about so please discuss it with them before potential injections.

Keep reading

There is only myocarditis and pericarditis in covid vaccinated children, study finds

A study was published in May 2024 by the Bennet Institute for Applied Data Science, a multidisciplinary team based at the University of Oxford. It was an observational study to assess the safety and effectiveness of the first and second doses of Pfizer-BioNTech’s (BNT162b2) covid injection in children and adolescents in England.  The injection was offered to this age group from September 2021 as part of the Government’s national covid injection campaign.

The study used the OpenSAFELY-TPP database and included adolescents aged 12-15 years and children aged 5-11 years, comparing unvaccinated and single-vaccinated children with those receiving a second dose.

It compared data for at least 1,678,668 children and adolescents comprising:

  • 820,926 unvaccinated adolescents.
  • 441,858 adolescents who had received a first dose.
  • 283,422 unvaccinated children.
  • 132,462 children who had received a first dose
  • There is no indication of how many adolescents and children who had received a second dose were included in the study.

The study used the incidence rate ratio (“IRR”), separately for children and adolescents, to compare unvaccinated outcomes to vaccinated outcomes and the first does (single-vaccinated) to those who had two doses of Pfizer’s “vaccine.”

IRR measures the relative difference in incidence rates between two groups.  An IRR greater than 1 indicates a higher incidence rate in one group compared to the other group. An IRR less than 1 indicates a lower incidence rate in one group compared to the other group. An IRR of 1 indicates no significant difference in incidence rates between the two groups.

Keep reading